Product Recalls: July 17, 2024 – August 14, 2024
Health Letter, September 2024
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.
For Class 1 recalls, there is a potential for serious injury or death.
For Class 2 recalls, there is a potential for serious adverse events but a lower chance of the drug causing serious injury or death than in a Class 1 recall.
CLASS I
acetaminophen extra strength tablets, 500 mg each, 100-count bottles. Packaged By: A-S Medication Solutions. Lot #: 4138197, exp. date: 10/31/2025.
clonazepam orally disintegrating tablets, 0.125 mg, 60 tablets per carton (10 blister cards containing 6 tablets each). Distributed by: Par Pharmaceutical. Lot #: 550147301, exp. date: 08/31/2026.
potassium chloride extended-release capsules, 750 mg, 10 mEq K, 100- or 500-count bottle. Manufactured by: Glenmark Pharmaceuticals Ltd. Lot #: 17221446 or 17221445, exp. date: May-31-24; Lot #: 17221393, 17221403, 17221405, 17221503 or 17221508, exp. date: Jun-30-24; 17221567, 17221566, 17221719 or 17221731, exp. date: Jul-31-24; Lot #: 17221891, 17221892, 17221900, 17221992 or 17222022, exp. date: Aug-31-24; Lot #: 17222056, 17222043, 17222068, 17222079, 17222099, 17222103, 17222114, 17222119, 17222188, 17222199, 17222209 or 17222200, exp. date: Sep-30-24; Lot #: 17222265 or 17222269, exp. date: Oct-31-24; Lot #: 17222527, 17222530, 17222583, 17222586, 17230051, 17230075 or 17230067, exp. date: Nov-30-24; Lot #: 17221197, 17221386 or 17221385, exp. date: May-31-24; Lot #: 17221489, 17221504 or 17221530, exp. date: Jun-30-24; Lot #: 17221561, 17221579, 17221568, 17221702 or 17221704, exp. date: Jul-31-24; Lot #: 17221898, 17221993 or 17222029, exp. date: Aug-31-24; Lot #: 17222300, 17222304, 17222278, 17222609 or 17222395, exp. date: Oct-31-24; Lot #: 17222589, 17222605 or 17222613, exp. date: Nov-30-24; Lot #: 17221738, exp. date: 07/31/2024; Lot #: 17222494, exp. date: 10/31/2024; Lot #: 17230533, exp. date: 01/31/2025; Lot #: 17232208, exp. date: 09/30/2025; Lot #: 17221823 or 17221830, exp. date: 07/31/2024; Lot #: 17221831, exp. date: 08/31/2024; Lot #: 17230248, 17230253, or 17230271, exp. date: 12/31/2024; Lot #: 17230796 or 17230820, exp. date: 02/28/2025; Lot #: 17230825, 17230833 or 17230840, exp. date: 03/31/2025; Lot #: 17231537, 17231540, 17231719 or 17231737, exp. date: 06/30/2025; Lot #: 17232111 or 17232164, exp. date: 09/30/2025.
CLASS II
Cardura XL (doxazosin) extended-release tablets, 4 or 8 mg, 30-count bottles. Distributed by: Roerig Division of Pfizer Inc. Lot #: 8147040, exp. date: June 2024; Lot #: 8163764, exp. date: March 2025; Lot#: 8147041, exp. date: June 2024; Lot #: 8163765, exp. date: March 2025.
fludrocortisone acetate tablets, 0.1 mg, 100 tablets per bottle. Manufactured by: Patheon, Inc. Lot #: CNSDH, exp. date: 6/30/2024; Lot #: CNWVM or CNWWH, exp. date: 07/31/2024; Lot #: CNXKW, CNXKY, CNXMB or CNXMH, exp. date: 09/30/2024; Lot #: CPBTP or CPBTV, exp. date: 11/30/2024.
gabapentin tablets, 600 mg, 500-count bottles. Manufactured by: Granules India Limited. Lot #: 1380040A, exp. date: July 31, 2025.
nitrofurantoin capsules, 100 mg, 100 capsules per bottle. Manufactured by: Sidmak Laboratories. Lot #: 231067 or 231069, exp. date: 04/30/2025.
potassium chloride extended-release capsules, 750 mg, 10mEq K, 30-count blister card or 100- or 500-count bottle. Manufactured by: Glenmark. Lot #: J0758674-021824, exp. date: 03/31/2025; Lot #: J0751898-011424, exp. date: 01/31/2025; Lot #: 17230074 or 17230221, exp. date: Dec-31-24; Lot #: 17230468, 17230479, 17230553, 17230543 or 17230561, exp. date: Jan-31-25; Lot #: 17230619 or 17230624, exp. date: Feb-28-25; Lot #: 17230879, 17230890, 17230918, 17230984, 17230996, 17231002 or 17231081, exp. date: Mar-31-25; Lot #: 17231102, 17231135 or 17231329, exp. date: Apr-30-25; Lot #: 17231369 or 17231513, exp. date: May-31-24; Lot #: 17231516 or 17231713, exp. date: Jun-30-25; Lot #: 17231909 or 17231903, exp. date: Jul-31-25; Lot #: 17231943, exp. date: Aug-31-25; Lot #: 17232166 or 17232179, exp. date: Sep-30-25; Lot #: 17230186, 17230192, 17230213, 17230278 or 17230399, exp. date: Dec-31-24; Lot #: 17230406, 17230412, 17230427, 17230444, 17230453 or 17230495, exp. date: Jan-31-25; Lot #: 17230574, 17230585, 17230608 or 17230629, exp. date: Feb-28-25; Lot #: 17230883 or 17230921, exp. date: Mar-31-25; Lot #: 17231087 or 17231339, exp. date: Apr-30-25; Lot #: 17231360, exp. date: May-31-25; Lot #: 17231711 or 17231745, exp. date: Jun-30-25; Lot #: 17231819, 17231820, 17231936 or 17231957, exp. date: Jul-31-25; Lot #: 17231998 or 17232012, exp. date: Aug-31-25; Lot #: 17232110, exp. date: Sep-30-25; Lot #: 17232114, exp. date: Aug-31-25; Lot #: 17232119 or 17232343, exp. date: Sep-30-25.
pravastatin sodium tablets, 80 mg, 90- or 500-count bottle. Manufactured by: Glenmark Pharmaceuticals Limited. Lot #: 17211249, 17211264, 17211266 or 17211286, exp. date: 6/30/24; Lot #: 17211525, 17211535 or 17211549, exp. date: 7/31/24; Lot #: 17211787 or 17211801,exp. date: 8/31/24; Lot #: 17212041, exp. date: 9/30/24; Lot #: 17212088 or 17212106, exp. date: 10/31/24; Lot #: 17212346 or 17212345, exp. date: 11/30/24; Lot #: 17220053, 17220054 or 17220055, exp. date: 12/31/24; Lot #: 17220309 or 17220310, exp. date: 1/31/25; Lot #: 17211290, exp. date: 6/30/2024.
venlafaxine hydrochloride extended-release capsules, 37.5 mg, 90- or 1,000-count bottles. Manufactured by: Zydus Lifesciences Ltd. Lot #: M213175, exp. date: 09/2024; Lot #: M213176, exp. date: 09/2024.
For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.
CONSUMER PRODUCTS
For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.